Style | Citing Format |
---|---|
MLA | Kheirollahi A, et al.. "Chondroitinase As a Therapeutic Enzyme: Prospects and Challenges." Enzyme and Microbial Technology, vol. 172, no. , 2024, pp. -. |
APA | Kheirollahi A, Sadeghi S, Orandi S, Moayedi K, Khajeh K, Khoobi M, Golestani A (2024). Chondroitinase As a Therapeutic Enzyme: Prospects and Challenges. Enzyme and Microbial Technology, 172(), -. |
Chicago | Kheirollahi A, Sadeghi S, Orandi S, Moayedi K, Khajeh K, Khoobi M, Golestani A. "Chondroitinase As a Therapeutic Enzyme: Prospects and Challenges." Enzyme and Microbial Technology 172, no. (2024): -. |
Harvard | Kheirollahi A et al. (2024) 'Chondroitinase As a Therapeutic Enzyme: Prospects and Challenges', Enzyme and Microbial Technology, 172(), pp. -. |
Vancouver | Kheirollahi A, Sadeghi S, Orandi S, Moayedi K, Khajeh K, Khoobi M, et al.. Chondroitinase As a Therapeutic Enzyme: Prospects and Challenges. Enzyme and Microbial Technology. 2024;172():-. |
BibTex | @article{ author = {Kheirollahi A and Sadeghi S and Orandi S and Moayedi K and Khajeh K and Khoobi M and Golestani A}, title = {Chondroitinase As a Therapeutic Enzyme: Prospects and Challenges}, journal = {Enzyme and Microbial Technology}, volume = {172}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Kheirollahi A AU - Sadeghi S AU - Orandi S AU - Moayedi K AU - Khajeh K AU - Khoobi M AU - Golestani A TI - Chondroitinase As a Therapeutic Enzyme: Prospects and Challenges JO - Enzyme and Microbial Technology VL - 172 IS - SP - EP - PY - 2024 ER - |